TGFB1 and neoplasm: Transforming growth tactor (TGF)-β has been shown to be a potent suppressor of NK-cell anti-tumor activity, including NK-cell ADCC, by inhibiting cytotoxicity, cytokine secretion, and NK-cell proliferation [34,35,36].